Biocon wins Health Canada approval for Yesintek autoinjector, expanding autoimmune biosimilar options in Canada. Read more.
Biocon shares trade near a 52-week high as its Malaysia unit wins EMA approval for Semglee production; read what’s next…
Indian pharma is entering its next growth phase as a new segment gains traction. We analyse four companies building this…
Biocon surged 8% to a 52-week high as block-deal buzz sent volumes up 180x despite a Q4 profit slump; track…
Track 40+ stocks turning ex-dividend this week, including M&M, Bajaj Holdings, Shriram Finance and Bharat Forge; check record dates now.
Biocon’s Malaysian partner Duopharma Biotech secures insulin supply contracts worth over MYR 225 million from Malaysia’s Ministry of Health to…
Watch Biocon and pharma stocks for a potential Nifty rebound as FIIs cover shorts—stay updated on key breakout levels!
Biocon turns to captive solar power from AMPIN to lower energy costs and carbon emissions
Britannia drops while Thermax, Sonata, Pidilite and Dabur rally after Q4FY26 earnings and major block deals.
Biocon founder Kiran Mazumdar-Shaw names niece Claire Mazumdar as successor under a phased five-year transition plan.
Claire,37, is the daughter of Shaw’s brother. She has studied biological engineering at MIT, then went to Stanford for two…
In a post on social network platform X, formerly Twitter, Shaw detailed out that Claire will eventually step into the…
Over 270 companies, including L&T, M&M, Swiggy, and Paytm, will announce earnings and possible dividends this week. Stay updated on…
Sensex & Nifty tank 1.5% as Vedanta adjusts for demerger and HUL slips post-Q4. Bajaj Finance defies the trend—here is…
India’s ₹10,000 crore Biopharma SHAKTI scheme marks a definitive shift from low-cost generics to high-value biologics, aiming to integrate local…
India’s Testing, Inspection, and Certification (TIC) market is projected to hit $10.9 billion by 2034, driven by stringent regulations in…
A sharp sell-off gripped markets as pharma stocks plunged on US tariff fears and rising crude prices dragged key sectors,…
Biocon’s Siddharth Mittal steps down as MD & CEO; Shreehas Tambe, a 30-year company veteran with 61 patents, takes over…